Patricia A Thistlethwaite MD
Cardiovascular Surgery
Professor of Surgery, UCSD
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 619-543-7777
Fax+1 619-543-2652
Dr. Thistlethwaite is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Thoracic Surgery - Independent, 1994 - 1997
Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 1989 - 1994
Harvard Medical SchoolClass of 1989
Certifications & Licensure
CA State Medical License 1997 - 2025
PA State Medical License 1994 - 1998
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Publications & Presentations
PubMed
- Autoimmune Encephalitis Induced by SARS-CoV-2 Infection Treated with Thymectomy.Cristian Puerta, Nolan M Winicki, Casandra E Besse, Yu Zhang, Mark Onaitis
Annals of Thoracic Surgery Short Reports. 2024-12-01 - Delta-like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials.Casandra E Besse, Nolan M Winicki, Cristian Puerta, Moises Hernandez, Jason X-J Yuan
Pulmonary Circulation. 2024-10-01 - 2 citationsApelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis.Hongryeol Park, Jian Song, Hyun-Woo Jeong, Max L B Grönloh, Bong Ihn Koh
Nature Communications. 2024-07-25
Press Mentions
Preventing Pulmonary Arterial Hypertension – an Incurable DiseaseMay 18th, 2022- Prevention of Pulmonary Arterial Hypertension-Incurable DiseaseMay 18th, 2022
- Targeting Molecular Pathway That Causes Pulmonary Arterial HypertensionMay 6th, 2022
Grant Support
- NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial HypertensionUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2028
- NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial HypertensionUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2028
- Molecular Mechanisms Of Pulmonary HypertensionNational Heart, Lung, And Blood Institute2002–2011
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
